Skip to main content
. 2019 Feb 28;9:3076. doi: 10.1038/s41598-019-38724-2

Table 4.

Adjusted ORs of ovarian stimulation protocols compared with natural cycle for pregnancy and neonatal outcomes among subgroup of different ART treatment.

Outcomes Maternal age < 35 Progesterone Early cleavage ET
Adjusted OR (95% Cl)a P value Adjusted OR (95% Cl)a P value Adjusted OR (95% Cl)a P value
PTD (<37 weeks)
   Natural cycle Reference Reference Reference
   Clomiphene alone 1.28 (1.04 to 1.58) 0.02 1.27 (1.11 to 1.44) <0.001 1.29 (1.07 to 1.56) 0.01
   Clomiphene + gonadotropin 1.16 (0.90 to 1.50) 0.26 1.22 (0.88 to 1.70) 0.24 1.26 (0.93 to 1.70) 0.13
   GnRH agonist 1.21 (0.996 to 1.47) 0.06 1.24 (0.99 to 1.56) 0.06 1.22 (0.99 to 1.48) 0.06
   GnRH antagonist 1.35 (1.08 to 1.69) 0.01 1.30 (1.01 to 1.68) 0.045 1.28 (1.02 to 1.60) 0.03
VPTD (<32 weeks)
   Natural cycle Reference Reference Reference
   Clomiphene alone 2.62 (1.62 to 4.26) <0.001 1.07 (0.76 to 1.52) 0.69 1.23 (0.80 to 1.89) 0.34
   Clomiphene + gonadotropin 2.49 (1.12 to 5.51) 0.03 1.52 (0.85 to 2.72) 0.16 1.69 (0.98 to 2.90) 0.06
   GnRH agonist 1.75 (0.87 to 3.49) 0.12 1.15 (0.74 to 1.77) 0.53 1.01 (0.63 to 1.62) 0.98
   GnRH antagonist 1.92 (0.90 to 4.12) 0.09 1.40 (0.80 to 2.44) 0.24 1.07 (0.67 to 1.70) 0.78
LBW (<2500 g)
   Natural cycle Reference Reference Reference
   Clomiphene alone 1.84 (1.48 to 2.29) <0.001 1.61 (1.45 to 1.80) <0.001 1.58 (1.43 to 1.74) <0.001
   Clomiphene + gonadotropin 1.81 (1.49 to 2.20) <0.001 1.57 (1.30 to 1.90) <0.001 1.58 (1.36 to 1.83) <0.001
   GnRH agonist 1.50 (1.27 to 1.78) <0.001 1.28 (1.11 to 1.48) 0.001 1.34 (1.20 to 1.50) <0.001
   GnRH antagonist 1.53 (1.26 to 1.85) <0.001 1.38 (1.17 to 1.62) <0.001 1.39 (1.21 to 1.59) <0.001
VLBW (<1500 g)
   Natural cycle Reference Reference Reference
   Clomiphene alone 3.00 (1.71 to 5.27) <0.001 1.84 (1.27 to 2.66) 0.001 1.77 (1.29 to 2.44) <0.001
   Clomiphene + gonadotropin 3.38 (1.73 to 6.63) <0.001 2.61 (1.19 to 5.72) 0.02 2.51 (1.53 to 4.12) <0.001
   GnRH agonist 1.86 (1.04 to 3.32) 0.04 1.73 (1.08 to 2.78) 0.02 1.39 (0.93 to 2.09) 0.11
   GnRH antagonist 2.02 (1.03 to 3.96) 0.04 1.95 (1.09 to 3.48) 0.02 1.37 (0.86 to 2.18) 0.19
SGAb
   Natural cycle Reference Reference Reference
   Clomiphene alone 1.97 (1.47 to 2.63) <0.001 1.58 (1.37 to 1.83) <0.001 1.65 (1.48 to 1.84) <0.001
   Clomiphene + gonadotropin 1.89 (1.48 to 2.41) <0.001 1.60 (1.31 to 1.95) <0.001 1.60 (1.37 to 1.88) <0.001
   GnRH agonist 1.35 (1.02 to 1.77) 0.030 1.09 (0.88 to 1.35) 0.44 1.25 (1.04 to 1.50) 0.02
   GnRH antagonist 1.41 (1.04 to 1.92) 0.03 1.32 (1.04 to 1.68) 0.03 1.29 (1.03 to 1.62) 0.03
LGAb
   Natural cycle Reference Reference Reference
   Clomiphene alone 0.82 (0.71 to 0.94) 0.006 0.88 (0.80 to 0.98) 0.02 0.94 (0.83 to 1.06) 0.32
   Clomiphene + gonadotropin 0.78 (0.65 to 0.93) 0.006 0.92 (0.74 to 1.14) 0.44 0.89 (0.76 to 1.04) 0.16
   GnRH agonist 0.96 (0.83 to 1.11) 0.60 1.09 (0.95 to 1.24) 0.20 1.01 (0.91 to 1.12) 0.84
   GnRH antagonist 0.95 (0.80 to 1.13) 0.54 1.11 (0.94 to 1.32) 0.22 0.996 (0.88 to 1.13) 0.96
CS
   Natural cycle Reference Reference Reference
   Clomiphene alone 1.27 (1.12 to 1.45) <0.001 1.18 (1.09 to 1.29) <0.001 1.18 (1.08 to 1.28) <0.001
   Clomiphene + gonadotropin 1.20 (1.01 to 1.43) 0.04 1.10 (0.94 to 1.30) 0.23 1.11 (0.98 to 1.26) 0.09
   GnRH agonist 1.06 (0.93 to 1.21) 0.35 1.05 (0.95 to 1.17) 0.33 1.04 (0.95 to 1.14) 0.36
   GnRH antagonist 1.05 (0.90 to 1.22) 0.53 1.15 (1.01 to 1.31) 0.03 1.03 (0.93 to 1.14) 0.56

aAdjusted for maternal age, infertility diagnosis, fertilization method, fetal sex and year.

bSGA was defined as being below the 10th percentile of the national reference. LGA was defined as being above the 10th percentile of the national reference.

CI, confidence interval; CS, cesarean section; LBW, low birth weight; LGA, large for gestational age; OR, odds ratio; PTD, preterm delivery; SGA, small for gestational age; VLBW, very low birth weight; VPTD, very preterm delivery.